Vasodilation and cardiopulmonary bypass: The role of Bradykinin and the pulmonary vascular endothelium

Chest

Volumn 120, Issue 6, 2001, Pages 1759-1761

  Conti, Vincent R ^a   McQuitty, Christopher ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; APROTININ; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; KALLIKREIN; NORADRENALIN; PHENYLEPHRINE; PLASMINOGEN ACTIVATOR; PROSTACYCLIN; TUMOR NECROSIS FACTOR; VASOPRESSIN;

BLEEDING; BLOOD VESSEL TONE; CARDIOPULMONARY BYPASS; EDITORIAL; ENDOTHELIUM; FIBRINOLYSIS; HEMODYNAMICS; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY CIRCULATION; METABOLISM; PERFUSION PRESSURE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SPLANCHNIC BLOOD FLOW; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION;

EID: 0035680887     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.120.6.1759     Document Type: Editorial

References (16)

1. Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent
2. Regional perfusion abnormalities with phenylephrine during normothermic bypass
3. Vasopressin for refractory hypotension during cardiopulmonary bypass
4. Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies
5. Systemic inflammatory response syndrome after cardiac operations
6. Release of vasoactive substances during cardiopulmonary bypass
7. Inhibition of kinin formation by a kallikrein inhibitor during extracorporeal circulation in open-heart surgery
8. Bradykinin stimulates tissue plasminogen activator release in human vasculature
9. Metabolic functions of the pulmonary circulation
10. Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function
11. Effect of bradykinin-receptor blockade on the response to angiotensin-converting enzyme inhibitor in normotensive and hypertensive subjects
12. Clinical significance of bradykinin liberation during cardiopulmonary bypass and its prevention by a kallikrein inhibitor
13. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass
14. Pulmonary metabolism of endothelin-1 during on-pump and beating heart coronary artery bypass operations
15. Effects of ischemia on pulmonary dysfunction after cardiopulmonary bypass
16. Extracorporeal circulation can induce hypotension by both blood-material contact and pump-induced platelet aggregation